We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+11.73%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$194M
AUM Growth
-$78M
Cap. Flow
-$87.1M
Cap. Flow %
-44.94%
Top 10 Hldgs %
40.18%
Holding
105
New
33
Increased
15
Reduced
10
Closed
42

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$10.1M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$4.72M
3
CNMD icon
CONMED
CNMD
+$4.58M
4
PODD icon
Insulet
PODD
+$4.57M
5
CI icon
Cigna
CI
+$4.53M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$9.42M
2
RMD icon
ResMed
RMD
+$8.01M
3
EW icon
Edwards Lifesciences
EW
+$4.71M
4
AGN
Allergan Inc
AGN
+$4.52M
5
EXAS
Exact Sciences
EXAS
+$4.41M

Sector Composition

Rank Sector Weight
1 Healthcare 54.96%
2 Financials 0%
3 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
51
CALL
STAAR Surgical
STAA
$1.24B
$743K 0.38%
+100,000
New +$731K
EIGR
52
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$636K 0.33%
75
– –
TNXP icon
53
Tonix Pharmaceuticals
TNXP
$197M
– –
0
– –
RCKT icon
54
Rocket Pharmaceuticals
RCKT
$382M
$474K 0.24%
+21,875
New +$513K
ZGNX
55
DELISTED
Zogenix, Inc.
ZGNX
$445K 0.23%
+40,625
New +$460K
EIGR
56
PUT
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$417K 0.22%
+49
New +$428K
OCRX
57
DELISTED
Ocera Therapeutics, Inc.
OCRX
$353K 0.18%
75,000
– –
TLOG
58
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$353K 0.18%
80,500
– –
DMK
59
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$317K 0.16%
+1,150
New +$497K
SCMP
60
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$311K 0.16%
+20,000
New +$310K
EVAR
61
DELISTED
Lombard Medical, Inc.
EVAR
$213K 0.11%
52,875
-283,150
-84% -$1.46M
SRPT icon
62
CALL
Sarepta Therapeutics
SRPT
$1.92B
$72K 0.04%
+5,400
New +$72K
BAX icon
63
PUT
Baxter International
BAX
$14.3B
– –
-128,870
Closed -$5.13M
BDX icon
64
PUT
Becton Dickinson
BDX
$49.4B
– –
-35,875
Closed -$4.87M
COO icon
65
CALL
Cooper Companies
COO
$15B
– –
-140,000
Closed -$5.67M
COO icon
66
PUT
Cooper Companies
COO
$15B
– –
-100,000
Closed -$4.05M
CRMD icon
67
CorMedix
CRMD
$573M
– –
-13,350
Closed -$127K
DXCM icon
68
CALL
DexCom
DXCM
$33.8B
– –
-400,000
Closed -$5.5M
EHTH icon
69
eHealth
EHTH
$39.1M
– –
-85,000
Closed -$2.12M
EXAS
70
DELISTED
Exact Sciences
EXAS
– –
-160,573
Closed -$4.41M
GERN icon
71
Geron
GERN
$1.05B
– –
-78,200
Closed -$254K
GILD icon
72
Gilead Sciences
GILD
$168B
– –
-22,500
Closed -$2.12M
ILMN icon
73
CALL
Illumina
ILMN
$29.1B
– –
-205,600
Closed -$36.9M
ISRG icon
74
Intuitive Surgical
ISRG
$142B
– –
-166,500
Closed -$9.42M
LLY icon
75
PUT
Eli Lilly
LLY
$1.08T
– –
-46,500
Closed -$3.21M
1 2
3
4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2015 Portfolio in Review

As of Q1 2015, Pura Vida Investments held 105 positions worth $194M, down 29% from $272M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Pura Vida Investments withdrew a net $87.1M in Q1 2015, closing 42 positions and reducing 10 holdings. Its most notable exit was Intuitive Surgical, an estimated $9.42M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 33% a quarter earlier, followed by Financials and Utilities.

Against the trend, Pura Vida Investments opened a new position in Baxter International worth $9.93M.

  • Pura Vida Investments's largest Q1 2015 buy was Baxter International: 266,945 shares worth $9.93M.
  • Pura Vida Investments added most to Jazz Pharmaceuticals in Q1 2015, an estimated $4.72M increase.
  • Pura Vida Investments's biggest Q1 2015 reduction was Edwards Lifesciences, cutting an estimated $4.71M.
  • Pura Vida Investments fully exited Intuitive Surgical in Q1 2015, selling an estimated $9.42M.
  • Pura Vida Investments's ten largest holdings make up 40% of its $194M portfolio in Q1 2015.
  • Pura Vida Investments opened 33 new positions and closed 42 in Q1 2015.
  • Pura Vida Investments's portfolio value fell 29% quarter-over-quarter to $194M.

Based on Pura Vida Investments's 13F filing for Q1 2015, filed 14 May 2015.